Tuesday, November 10, 2026

Parkinson Essays

 Number TWO

Six Men on the Streets of London: James Parkinson and the Art of Seeing

An alternative reading of An Essay on the Shaking Palsy (1817)

There is something wonderfully improbable about the origins of Parkinson's disease. In 1817, a London surgeon published a description of a neurological disorder based on six men, including three who were not his patients. Two were strangers he encountered on the streets, while another he observed without conducting a formal examination. From these fragmentary encounters, James Parkinson constructed a disease that physicians still recognize two centuries later.

What deserves attention is not simply his diagnostic accuracy, but the peculiar kind of scientific imagination involved.

Parkinson's achievement depended on seeing time where other observers saw only symptoms. A man with a trembling hand, another with a stooped posture, and a third propelled forward by an increasingly rapid gait might ordinarily have been assigned to different diagnostic categories. Parkinson proposed that they represented different moments in the history of one illness.

This was an audacious intellectual maneuver. He effectively converted six individuals into a longitudinal study, using differences among patients to reconstruct changes occurring within a patient. His evidence was cross-sectional, but his argument was temporal.

The resulting account has an almost cinematic quality. The reader watches a disorder unfold: a slight tremor, initially confined to one hand; increasing difficulty with ordinary activities; altered posture and gait; progressive dependence. Parkinson makes the disease visible by showing what happens next.

There is also something distinctly urban about his discovery. London itself becomes an extension of the examining room. The physician encounters neurological disease not only among those who seek medical attention, but among strangers moving through the city. The streets supply observations that the medical practice alone could not.

Yet this observational freedom carried an important limitation. Parkinson could recognize patterns of movement without reliably establishing their causes. He could infer progression without following every patient through its course. And he could describe a syndrome without knowing whether all six men shared the same underlying pathology.

Modern medicine, with its biomarkers, imaging, diagnostic criteria, and molecular classifications, has not entirely escaped this problem. We continue to debate whether clinically similar patients have one disease, several diseases, or different biological routes to a common phenotype.

Indeed, Parkinson's own disease has become an example of that uncertainty. The familiar clinical syndrome encompasses substantial variation in progression, cognition, autonomic dysfunction, and underlying pathology. Even the boundaries of Parkinson's disease remain subjects of scientific discussion.

Perhaps the deepest lesson of the 1817 essay is that diseases are not simply found in nature, already labeled and waiting to be discovered. They become recognizable when an observer identifies meaningful relationships among otherwise disconnected facts.

Parkinson did not possess the tools to explain the disorder he described. What he possessed was an extraordinary ability to recognize its narrative.

He saw six men. He imagined one disease moving through time. And medicine has spent the following two centuries investigating the biological reality behind that imaginative act.

#

#

#

FIRST ESSAY - SECOND VERSION OF IT


James Parkinson's 1817 Essay: The Discovery of a Disease and the Defense of an Idea

A modern reading of An Essay on the Shaking Palsy

In 1817, James Parkinson published a small book about a disease that had no name, no established place in medical classification, and no known anatomical basis. He had observed six men, three of them outside his own practice, and believed that their various afflictions represented different stages of a single progressive disorder. He was sufficiently persuaded to publish his conclusions, but sufficiently uncertain to spend much of his preface explaining why he had done so.

It is an unusually attractive beginning to a medical discovery. Parkinson was not announcing a breakthrough, much less proclaiming a revolution. He was asking other physicians to look more closely at something he believed they had been overlooking.

The history of medicine offers plenty of examples of innovators who expected a hostile reception. Harvey had challenged the prevailing account of circulation; Pasteur would later overturn familiar explanations of fermentation and infection. Parkinson's problem was somewhat different. He was not so much challenging an established theory as proposing that a collection of familiar symptoms belonged together. Tremor was well known. So were stooped posture, difficulty walking, and involuntary movements. What was new was the suggestion that these were not separate complaints but successive expressions of one disease.

Parkinson understood that the distinction mattered. A physician who saw only tremor might prescribe for tremor. A physician who recognized the beginning of a progressive illness might think differently about prognosis, treatment, and the urgency of intervention.

An Argument Built Around Its Own Weaknesses

The preface is perhaps the most revealing part of the book. Parkinson acknowledges that his account rests partly on conjecture and analogy rather than the anatomical evidence he regards as the proper foundation of pathology. He knows perfectly well what is missing. He has no autopsies establishing a characteristic lesion, no experimental confirmation, and only a handful of clinical histories.

Rather than conceal these deficiencies, he makes them part of his argument. The disease is sufficiently serious, and its early manifestations sufficiently easy to overlook, that publication may encourage physicians with greater opportunities to investigate it. He hopes particularly for anatomical examination.

There is something admirable about this position. Parkinson does not confuse the strength of his observations with the strength of his explanation. He believes he has recognized a clinical pattern; he is much less certain why it occurs. His willingness to separate these propositions is one reason the essay remains readable long after its anatomical speculations have been discarded.

The book itself follows an orderly progression. Parkinson defines the disorder, describes its course, presents his cases, examines earlier medical literature, proposes a possible anatomical explanation, and considers treatment. The arrangement is deliberate. Each section addresses a different obstacle to accepting the existence of the disease.

The earlier literature is especially important. Parkinson was not the first physician to describe shaking, festination, or disturbances of voluntary movement, and he makes no such claim. His task is to show why the existing descriptions, although individually accurate, had failed to capture the relationship among these phenomena.

Six Patients and the Passage of Time

The six cases would scarcely satisfy the evidentiary expectations of a modern clinical journal. Three men were not Parkinson's patients. Two were encountered in the streets of London, and one was observed without a formal examination. Their histories were incomplete, their examinations inconsistent, and their eventual pathological diagnoses unknowable.

Yet the descriptions are often wonderfully precise. Parkinson notices the asymmetry of early tremor, the increasing difficulty of ordinary movements, the peculiar acceleration of gait, and the discrepancy between a patient's intentions and his body's performance. He describes men who wish to walk at an ordinary pace but find themselves hurrying forward, struggling to keep their feet beneath them.

The familiar clinical picture emerges not from any single patient but from the relationship among the six. Parkinson arranges observations made at different moments in different lives into a proposed sequence of deterioration.

That reconstruction is both the essay's greatest strength and an important source of uncertainty. He could not know that every patient would necessarily pass through the stages he described. Some of the men may have had disorders that would now be classified separately. Nevertheless, the clinical progression he imagined was sufficiently coherent to become the foundation of a recognizable syndrome.

It is easy to underestimate the originality of this achievement. Medical discoveries are often pictured as the identification of something previously invisible: a microorganism, an anatomical lesion, a biochemical abnormality. Parkinson's discovery required no new instrument. It required a new arrangement of things that physicians could already see.

The Anatomy of a Mistake

When Parkinson turns from clinical description to anatomical explanation, the essay becomes less successful, although perhaps more interesting.

He proposes that the disease arises in the upper cervical spinal cord, with involvement extending toward the medulla oblongata. His reasoning depends partly on the apparent preservation of intellect and sensation. If the mind remains clear, he reasons, the principal disturbance may lie below the structures responsible for higher cerebral functions.

The conclusion is wrong. Modern accounts place degeneration of dopaminergic neurons in the substantia nigra and dysfunction of broader neural networks near the center of Parkinson's disease, although its pathology extends well beyond a single structure.

Still, Parkinson's mistake is instructive. He was reasoning from the available clinical evidence toward an anatomical location, much as later neurologists would do with considerably better knowledge of the nervous system. The problem was not that he neglected anatomy. It was that he took a limited understanding of neurological function as the framework within which his observations had to fit.

His assertion that intellect remains unaffected also illustrates the hazards of defining a disease from a small and selected collection of patients. Cognitive impairment, psychiatric symptoms, and autonomic dysfunction are now recognized as important parts of Parkinson's disease, although their expression varies greatly.

There is a certain irony here. Parkinson's clinical observations proved more durable than the anatomical reasoning he used to explain them. The disease survived the theory.

Treatment Before Understanding

The final chapter turns to treatment, and the modern reader encounters the familiar medical armamentarium of the early nineteenth century: bloodletting, blistering, and the production of discharging sores near the presumed site of disease.

These recommendations are difficult to read without wincing. Yet Parkinson's reasoning is neither casual nor indifferent to suffering. If the disease begins as a localized pathological process and progresses to irreversible damage, he argues, intervention might succeed early even when treatment of advanced cases is hopeless.

The therapeutic proposals follow naturally from the anatomical hypothesis. Unfortunately, an internally consistent treatment can be entirely ineffective when its underlying model is mistaken.

Parkinson also understood that recognition of the earliest manifestations was essential. By the time the characteristic disorder was unmistakable, opportunities for useful intervention might already have passed. That concern remains familiar to anyone working on neurodegenerative disease today.

What Parkinson Actually Discovered

There is a temptation, when reading old medical literature, to divide its contents into two categories: observations that anticipated modern science and errors that later science corrected. This is satisfying but not particularly illuminating. It turns the history of medicine into a competition in which the present always wins.

Parkinson's essay is more interesting when read on its own terms. He was working in a medical world where diseases were increasingly understood as processes with characteristic histories and anatomical causes, but where the means of establishing those causes remained rudimentary. He brought together clinical observation, existing medical classifications, anatomical speculation, and a sense of therapeutic urgency. The resulting argument was incomplete, sometimes mistaken, and remarkably productive.

The most consequential part was not his proposed location of the lesion, or even his description of tremor. It was his decision to treat a sequence of changing symptoms as evidence of a single underlying process.

That decision raises a question that medicine has never entirely resolved. When do several symptoms constitute one disease? When does one apparent disease turn out to contain several? Modern molecular pathology has repeatedly forced physicians to divide familiar clinical entities into distinct biological categories, just as clinical observation sometimes brings apparently unrelated manifestations together.

Parkinson's disease itself remains subject to such questions. Patients sharing its characteristic motor syndrome may differ considerably in cognition, autonomic involvement, progression, and pathology. Whether future classifications will preserve today's boundaries is not certain.

James Parkinson could not have anticipated the biological discoveries that would follow his essay. But he recognized something more fundamental about clinical medicine: that the meaning of an observation often depends on its relationship to other observations, including those separated from it by years.

He saw a disorder taking shape across six lives. His explanation was wrong in important particulars, but the pattern he recognized was real enough to outlive him by two centuries.

That is a substantial achievement for a surgeon who began by apologizing for the inadequacy of his evidence.


####

#

#
#
ESSAY THREE - BONUS - DEFINING

FLECK AND PARKINSON - WHAT IS A DISEASE

The separation of syphilis and gonorrhea became broadly established in European medicine between about 1830 and 1850, with Philippe Ricord's work in Paris providing the decisive clinical evidence in the 1830s. Bacteriology supplied a more definitive etiological distinction between 1879 and 1905.

Your reference to Ludwik Fleck is especially apt. In Genesis and Development of a Scientific Fact (1935), Fleck uses the history of syphilis to show that a disease is not simply a preexisting object waiting for physicians to recognize it. Its identity emerges through changing clinical concepts, laboratory techniques, and what Fleck calls thought collectives.

A remarkably long process of separating two diseases

Period

Development

1500s–1700s

Syphilis and gonorrhea were often grouped under broad concepts of venereal disease.

1767

John Hunter's famous inoculation experiment appeared to support a single venereal poison.

1793

Benjamin Bell argued that gonorrhea and syphilis were distinct diseases.

1830s

Philippe Ricord's clinical investigations established the distinction much more convincingly.

1879

Albert Neisser identified the gonococcus, the organism responsible for gonorrhea.

1905

Fritz Schaudinn and Erich Hoffmann identified Treponema pallidum, the agent of syphilis.

The extraordinary story of John Hunter

The episode involving John Hunter is particularly revealing.

In 1767, Hunter inoculated material believed to be gonorrheal discharge into a human subject, traditionally said to be himself. The subject subsequently developed a chancre and manifestations of secondary syphilis.

Hunter interpreted this as evidence that gonorrhea could develop into syphilis—that they were manifestations of one disease.

Modern historians believe the donor probably had both infections. Furthermore, whether Hunter actually performed the inoculation on himself is disputed. His published account describes the recipient in the third person.

An experiment intended to settle a controversy instead reinforced the wrong disease classification for decades.

ASM Journals+1

Ricord's decisive intervention, 1831–1838

Philippe Ricord (1799–1889), working at the Hôpital du Midi in Paris, undertook an extensive program of clinical investigation and inoculation experiments.

Between 1831 and 1837, he performed more than 2,500 inoculations using material from patients' lesions. His 1838 Traité pratique sur les maladies vénériennes helped establish that gonorrhea and syphilis were distinct entities.

These experiments would be ethically unacceptable today, but they were influential in resolving the longstanding controversy.

JLUpub

The Fleck connection—and the Parkinson connection

Fleck's argument is subtler than simply saying that physicians made mistakes until better experiments arrived.

He argues that the very concept of syphilis emerged gradually from a heterogeneous collection of genital lesions, skin disorders, constitutional symptoms, and moral assumptions about sexuality. The disease acquired increasingly precise boundaries through successive transformations of medical thinking.

This suggests a fascinating contrast with James Parkinson.

  • Parkinson (1817): Six apparently different clinical presentations were assembled into one disease.

  • Ricord (1838): Presentations long grouped together under venereal disease were separated into distinct diseases.

  • Fleck (1935): The historical processes of combining and separating observations became evidence for a general theory of how scientific facts develop.

The biological distinction between syphilis and gonorrhea was real all along. But the medical categories through which physicians recognized that distinction were historically constructed.

That is the particularly useful Fleckian insight: the natural world constrains disease classification, but it does not tell physicians in advance where to draw every boundary.

And this remains relevant to Parkinson's disease today. Are the various phenotypes of Parkinson's manifestations of one underlying disease, or are we grouping several biological diseases under one clinically useful name?

The distinction between clinical syndromes and etiologically defined diseases remains as important in 2026 as it was in 1838.   END

For a primary source, see Fleck's Genesis and Development of a Scientific Fact (1935), especially Chapter 1, How the Modern Concept of Syphilis Originated.

 

Sunday, November 1, 2026

Haney / Babbitt. Haney / Gecko.

 

Haney / Babbitt

Sinclair Lewis’s George F. Babbitt and Green Acres’ Mr. Haney represent two branches of American enterprise: the businessman who believes his own sales pitch and the businessman who hopes somebody else will. Babbitt requires a community of shared values. Haney requires a deposit.

Both sell property, but their deeper commodity is confidence. Babbitt’s real-estate business belongs to a world of civic clubs, respectable opinions, and collective self-congratulation. Haney achieves comparable effects beside a truck. Where Babbitt needs the organized business leadership of Zenith to certify that commerce serves humanity, Haney is prepared to certify this himself.

Their language reveals the distinction. Babbitt speaks in slogans whose authority comes from everyone repeating them. Haney offers explanations whose ingenuity increases with the customer’s resistance. Babbitt knows a proposition is sound because every successful man agrees. Haney knows a proposition needs work because Mr. Douglas has noticed the roof.

Yet Babbitt possesses something Haney seldom displays: an unhappy inner life. His intermittent rebellion against conformity suggests that prosperity has failed to deliver the existence it advertised. He becomes, in effect, a dissatisfied customer of his own philosophy. Lewis allows him enough self-awareness to suffer, though insufficient independence to make suffering reliably useful.

Haney enjoys the advantages of a recurring comic character. He need not resolve a spiritual crisis before returning next week with a secondhand water heater. His identity survives every exposure because exposure is already included in the business model.

The pairing therefore illuminates two relationships between commerce and belief. Babbitt depends on the conviction that business success establishes moral worth. Haney demonstrates how much business can be conducted after that conviction has become unnecessary.

Babbitt needs to believe he is a pillar of the community. Haney would be pleased to sell him one.

##

Haney / Gecko


Gordon Gekko, the financier of Wall Street, can be understood as Mr. Haney with access to capital markets. In this interpretation, Gekko stands on the shoulders of giants, although Haney would charge him for the ladder.

Both men practice the art of discovering that another person’s assets would be better situated in their own possession. Both present self-interest as a service. Haney arrives when Oliver Douglas needs something; Gekko arrives when a company possesses something. The distinction is modest but consequential.

Their principal difference is rhetorical scale. Haney offers a dubious bargain. Gekko offers a theory of civilization. “Greed is good” elevates the sales pitch into a political philosophy: what benefits the acquisitive individual supposedly improves the system. Haney, working with fewer syllables and a smaller wardrobe budget, generally confines his claims to the exceptional value of the merchandise.

Yet Haney’s world imposes a limitation that Gekko’s financial machinery helps overcome: Haney must usually face the person he is fleecing. Oliver can inspect the tractor, identify its missing parts, and shout. In Wall Street, the proposed dismantling of Bluestar Airlines separates financial opportunity from the workers who will bear its consequences. Distance permits an elegance unavailable in the farmyard.

The comic forms differ accordingly. Haney’s schemes must leave Oliver sufficiently solvent for next week’s episode. Gekko’s ambitions carry no such obligation to preserve the supporting cast. Haney is a recurring nuisance; Gekko threatens the conditions under which the story’s ordinary people can continue living.

Neither comparison requires making Haney an innocent. His advantage is candor by transparency: the audience recognizes the hustle almost immediately. Gekko’s expensive surroundings invite the possibility that predation becomes wisdom above a certain income.

Haney sells you a tractor that does not work. Gekko explains why eliminating your job means the economy does.


Sunday, October 25, 2026

Test: Zhivago

 

Saturday, September 12, 2026

Dr Zhivago Revisited: The Secret Lamarck/Lysenko Deal

 

The Balalaika Conspiracy:
Doctor Zhivago’s Last-Minute Concession to Lysenko


David Lean’s Doctor Zhivago begins with General Yevgraf Zhivago searching for a young woman named Tanya Komarova, whom he suspects is the lost daughter of his half-brother Yuri and Lara. The film then retreats into its enormous central flashback. Only in the final moments does it complete the frame: as Tanya walks away, Yevgraf notices that she carries a balalaika. Her companion tells him that she does not merely play it; “she’s an artist.” Yevgraf smiles. Yuri’s mother had also possessed an extraordinary gift for the instrument.

“Ah,” he says. “Then it’s a gift.”

Ordinarily, this is taken as a delicate final suggestion that Tanya really is Yuri’s daughter. That interpretation, however, overlooks the scene’s remarkable biological claim. Tanya has apparently inherited not merely musical aptitude, but proficiency with one particular Russian stringed instrument—an ability first acquired through practice by her paternal grandmother. This is not Mendelian genetics. It is Lamarckism with three strings.

We propose that the balalaika ending was imposed upon the film as a discreet tribute to Trofim Lysenko, the Soviet agronomist who rejected conventional genetics and maintained that acquired characteristics could be transmitted to later generations. 

  • Wheat exposed to winter could beget winter-ready wheat. 
  • A woman who mastered the balalaika could apparently beget a granddaughter who did the same.

Several features support the hypothesis.

First, the Tanya framework is structurally detachable. The great romantic narrative would remain intact without it. Its industrial setting, older Yevgraf and unfamiliar young couple belong to a visibly separate layer of the production. The balalaika itself arrives only in the final seconds, too late to influence the plot but precisely in time to dictate its ideological meaning. This is the signature of a late political insertion: narratively unnecessary, symbolically overdetermined and positioned where no audience can escape before receiving it.

Second, Yevgraf’s reasoning is otherwise inexplicable. A balalaika is not mitochondrial DNA. Thousands of Russians played one. Yet the general treats Tanya’s virtuosity as near-genealogical confirmation. The film asks the audience to accept a chain of inheritance running from Yuri’s mother, through Yuri—who exhibits no comparable instrumental ability—to Tanya. The trait has passed silently through one generation and then flowered in the next. It is difficult to imagine a more cinematic demonstration of an acquired characteristic awaiting favorable environmental conditions.

Third, the crucial word “gift” is suspiciously diplomatic. To Western audiences it means innate music talent. To a Lysenkoist censor it could signify specifically the genetic transmission of environmentally cultivated capacity. One line thus supports two mutually incompatible theories of heredity. It is less dialogue than a carefully negotiated communiqué.

The probable production history can be reconstructed. At some late stage, several vital reels got entangled in an otherwise obscure political embargo. Producer Carlo Ponti, needing their release, offered the balalaika scene as a bargaining counter: no overt praise of Soviet biology, certainly, but a final image showing that the disciplined achievements of one generation might reappear spontaneously in another. The officials received their ideological gesture; Ponti received his reels; Lean received an ending sufficiently poetic that nobody would examine its agronomy.

And fourth - There remains the most intriguing evidence. In the hydroelectric-dam sequences, a heavyset, balding man of approximately Lysenko’s age can—or can almost—be detected among the background workers. He never faces the camera squarely. Production records do not identify him. Enlargements are inconclusive. Yet his placement is suggestive: he stands within the vast machinery of Soviet modernization while Yuri’s supposedly inherited balalaika talent is being rediscovered nearby.

  • Could Lysenko himself have been smuggled into the film as an extra, memorializing the bargain?

Chronology, geography and ordinary probability all argue strongly against it. On the other hand, these objections rely upon conventional evidence—the very epistemological regime Lysenko devoted his career to overcoming. Absence of documentation may therefore be counted, in appropriately Lysenkoist fashion, as evidence that the theory has adapted successfully to hostile archival conditions.

Conclusion

The closing scene of Doctor Zhivago is consequently more than a sentimental recognition scene. It is a compressed parable of heredity, diplomacy and film finance. Tanya does not inherit Yuri’s poetry, Lara’s courage or even her grandmother’s general musicality. She inherits the balalaika.

The instrument is not simply a family keepsake. It is the acquired characteristic made audible.

Test: RePosting Mark Twain News Critic

 

Mark Twain as Movie Critic: Sound of Music, Love Actually

 

The Sound of Music

I had supposed that a convent existed to protect its inmates from the world. In this picture it serves chiefly to protect the world from a young woman named Maria, and presently abandons even that duty.

She is dispatched to a household containing seven children and a retired naval captain, an arrangement which would seem to require either a governess or an armistice.

The captain governs by whistle. Maria governs by song. The children, having examined both constitutions, elect the one which permits excursions.

Miss Andrews sings beautifully. Indeed, she sings so beautifully that one almost forgives the frequency with which she discovers an occasion to do so.

The baroness is the only person present who appears equipped to conduct an ordinary afternoon. Naturally, she must go.

Meanwhile Austria is being annexed, a development which introduces some welcome uncertainty into a plot whose matrimonial outcome has been visible from Switzerland.

At last the family escapes over the mountains. The youngest children manage this remarkably well, considering that their principal training has been in staircases.

It is a handsome and affecting entertainment. I left with renewed faith in children, mountains, and the wisdom of keeping a governess’s references on file.


Love Actually

This picture undertakes to prove that love is everywhere, and employs nearly the entire British acting profession to prevent the proposition from escaping examination.

There are so many courtships that I began assigning them numbers, a system defeated when several persons took an interest in the wrong number.

The prime minister falls in love with a member of his staff. In America this would require a committee; in England it requires a Christmas concert.

A gentleman courts his best friend’s wife by exhibiting written statements at her doorstep. He has evidently mistaken the absence of spoken testimony for innocence.

Another gentleman proposes marriage in Portuguese, a language he has recently acquired for the purpose. I admired his economy. Most husbands spend years learning how to be misunderstood.

Miss Thompson supplies the picture with its conscience. Her husband supplies it with the need for one.

The airport scenes suggest that the authorities will waive any regulation upon satisfactory evidence of a romantic emergency.

I laughed frequently and was moved against my better preparations. The machinery is shameless, but well tended.

I cannot certify that love is everywhere. In this picture, however, it has secured all the available parking.

Saturday, October 24, 2026

CHAT GPT alternative essay on CMS Elective Exclusion

Main blog; Claude essay on elective exclusion case law

Here:  Alternative from Chat GPT

#

CMS Exclusion Authority and the Lessons of Three Appellate Decisions

CMS’s expanded role in excluding providers from federal healthcare programs brings renewed attention to a longstanding question: how much discretion does the government have to remove a provider, and what must it demonstrate before doing so?

Three federal appellate decisions offer useful perspectives. One concerns laboratory referral arrangements, another the responsibility of pharmaceutical executives, and a third allegedly unnecessary medical procedures. Together, they distinguish the legal basis for exclusion, the justification for its duration, and the procedures available to challenge it.

A New Enforcement Role Under an Existing Statute

On October 14, 2026, HHS delegated to the CMS Administrator the Secretary’s permissive-exclusion authority under §1128(b) of the Social Security Act, codified at 42 U.S.C. §1320a-7(b). OIG retains its authority. The delegation expressly withholds authority to conduct hearings or issue regulations and requires compliance with applicable departmental procedures and rules. It changes who can exercise the authority without rewriting the statutory grounds for exclusion.

“Permissive” means that exclusion is authorized rather than automatically required once a qualifying circumstance exists. The circumstances vary considerably: some involve convictions, while others involve unnecessary services, substandard care, prohibited financial arrangements, or failures to provide required information. Consequently, permissive exclusion is not synonymous with exclusion without a conviction, although important provisions require none.

The following cases arose from HHS/OIG enforcement. Their relevance to CMS lies in their interpretation of the same statutory authority and the constraints surrounding its exercise.

Hanlester: A Laboratory Violation Did Not Necessarily Justify Exclusion

Hanlester Network v. Shalala, 51 F.3d 1390 (9th Cir. 1995)

Hanlester organized laboratory joint ventures in which physicians could purchase partnership interests. SmithKline BioScience Laboratories managed the laboratories and performed most of their testing. The government alleged that financial benefits offered to physician investors improperly induced referrals and that the relationship with SmithKline also involved unlawful remuneration.

HHS pursued permissive exclusions under §1128(b)(7), which reaches specified prohibited conduct, including kickback violations. The Ninth Circuit upheld certain entities’ liability for their marketing agent’s conduct but reversed the exclusions. It emphasized exclusion’s purpose of protecting programs and patients from future harmful conduct. On the particular record, the entities’ liability was vicarious, and the court concluded that the relevant untrustworthiness ended when the agent left.

The distinction is consequential: a finding of misconduct and a justification for exclusion are separate questions. The decision does not establish that dismissing an employee always prevents exclusion; its reasoning depended on the evidence and attribution of responsibility.

A qualification concerns the case’s separate interpretation of kickback intent. Congress subsequently eliminated the requirement for actual knowledge of the statute or specific intent to violate it. That older portion of Hanlester should not be presented as current law.

Friedman: Exclusion Was Authorized, but Twelve Years Required a Better Explanation

Friedman v. Sebelius, 686 F.3d 813 (D.C. Cir. 2012)

Purdue Frederick employees had promoted OxyContin as less addictive and less susceptible to abuse than other pain medications. Three senior executives pleaded guilty to misdemeanor misbranding under the responsible corporate officer doctrine. Their pleas admitted responsibility and authority to prevent or correct the misrepresentations; the doctrine did not require personal knowledge of the underlying fraudulent conduct.

HHS ultimately imposed twelve-year exclusions. The executives challenged both the statutory basis and the duration.

The D.C. Circuit held that §1128(b)(1) authorized exclusion because the misdemeanor convictions related to fraud. However, it remanded because HHS had not adequately explained the unusually lengthy exclusions in light of prior agency decisions. The court did not declare twelve years categorically impermissible; it required a reasoned explanation.

For policymakers, the case demonstrates that a lawful basis for exclusion does not settle its appropriate length. An agency changing enforcement intensity must explain its decisions and address relevant precedent. Unlike Hanlester, this case depended on criminal convictions, although the convictions did not require proof that the executives personally intended fraud.

Thorbus: Challenging Exclusion Does Not Necessarily Stop It

Thorbus v. Bowen, 848 F.2d 901 (8th Cir. 1988)

Dr. Ruben Thorbus practiced in rural Minnesota, where approximately 60% of his clinic patients received Medicare or Medicaid. Medical reviews identified allegedly excessive diagnostic endoscopic procedures and deficiencies in care. After giving him an opportunity to present evidence and argument, HHS imposed a five-year exclusion.

The cited authorities included §1128(b)(6)(B), covering substantially unnecessary or substandard services, and a separate quality-of-care provision. Thorbus requested an administrative hearing but also sought a federal court injunction to prevent exclusion while administrative proceedings continued.

The Eighth Circuit upheld the refusal to grant an injunction. It found no established constitutional violation and concluded that the asserted financial and reputational harm did not justify relief when balanced against potential harm to patients.

The decision illustrates the practical importance of timing: an available appeal does not necessarily postpone an exclusion. Its holding concerned interim relief and procedural adequacy, however, rather than a final judicial resolution of every disputed medical service.

Implications for CMS Policy

These decisions identify three questions that should remain distinct as CMS exercises its authority:

  • Is there a statutory basis for exclusion? The government must establish the elements of the particular provision invoked.

  • Is the exclusion decision adequately justified? The protective rationale, supporting evidence, and duration can be subject to judicial scrutiny.

  • When can the provider obtain review or interim protection? Procedures differ by statutory ground. Section 1128(b)(7), for example, generally provides for a hearing before exclusion takes effect, subject to a health-or-safety exception.

For laboratory policy, another distinction is essential. Excessive charges under §1128(b)(6)(A) and unnecessary services under §1128(b)(6)(B) are different grounds. The former addresses charges substantially above the provider’s usual charges, subject to statutory qualifications. The latter concerns patient need and professional standards. Thorbus therefore does not establish how the excessive-charge provision applies to laboratory prices. Nor does Hanlester, which involved referral arrangements rather than fee-schedule levels.

The significance of CMS’s delegation is institutional: the agency administering payment programs now has a broader route to pursue exclusion itself. The appellate cases underscore that this enforcement capacity remains tied to specific statutory grounds, evidentiary records, and reasoned decisions. Public concern about fraud may explain a stronger enforcement priority; each exclusion must still be justified under the law governing that action.



#


 

Tuesday, October 20, 2026

Evaluating the Value of Four-Transcript Analyses for Biz Deals

 Recently we looked at "four investor call" analyses for Bioreference/Labcorp, Invitae/Bankruptcy, and Myriad/Labcorp.  Quo vadis?

##

The value of “Four Transcripts” is that it lets us test a company’s explanation against its own subsequent results. One call offers a carefully prepared account of the present and a forecast of the future. Four calls let us ask whether the forecast arrived, whether the explanation changed, and whether the original business objective still made sense.

Across BioReference, Invitae, and Myriad Prenatal, that approach produced three different findings. Their common destination—Labcorp—should not obscure how differently they arrived there.

Three cases, three different problems

CaseManagement’s central propositionWhat the sequence revealedPrincipal lesson
BioReferenceA smaller, more focused laboratory could achieve sustainable profitabilityOperating improvements were real, but recurring profitability remained unproven; a transaction-related benefit complicated the apparent earnings improvementImproving a business does not establish that its current parent is its best owner
InvitaeRestructuring and refinancing could provide enough time to reach a sustainable business modelMargins improved and cash burn fell, yet financing needs and the capital structure remained decisiveAn operating turnaround can progress while the corporation’s ability to finance it deteriorates
Myriad PrenatalCustomer recovery, dedicated selling, and FirstGene could restore growthRecovery disappointed, explanations broadened, and prenatal increasingly competed with oncology for resourcesA promising business can lose its place in a company’s investment priorities without becoming technologically obsolete

These are interpretations of the three supplied studies, rather than a new independent audit of every underlying transcript and filing.

BioReference: the revealing feature was persistence. Its public strategy remained remarkably consistent: reduce costs, concentrate the business, improve the testing mix, and grow 4Kscore. The useful observation was how long the anticipated profitability remained ahead of the company.

The report’s most concrete analytical finding was the distinction between reported and recurring operating performance. A reported quarterly operating profit included a divestiture-related benefit large enough to reverse the apparent conclusion about the continuing operation. That is something an enthusiastic call summary could easily miss.

The sale did not prove that the turnaround was fictitious. Restructuring could improve both the prospects for continued ownership and the price obtainable from a buyer. The calls demonstrated an operational improvement program; they did not disclose when selling became the preferred corporate strategy.

The BioReference study provides that distinction: BioReference_Terminal_Year_OPKO_Case_Study_Updated_PAMA(2).pdf

Invitae: the revealing feature was the coexistence of improvement and danger. This is the strongest answer to the claim that earnings calls are merely hype. Some of the positive operating developments were substantive. Gross margins improved, spending fell, and near-term debt maturities were addressed. Those achievements nevertheless failed to establish that the company could finance itself through to sustainability.

The decisive change was the transition from a turnaround supported by expected financing flexibility to a formal going-concern warning and a capital-structure review. The report carefully distinguishes that management assessment from a supposed longstanding auditor warning.

The important analytical question was therefore not whether management could identify genuine progress. It could. The question was whether that progress solved the company’s binding financial constraint.

The Invitae study captures that separation: INVITAE Lst Four Calls.pdf

Myriad Prenatal: the revealing feature was the evolution of the explanation. The early account centered on an ordering-system disruption and recovering displaced customer volume. Later calls placed increasing weight on dedicated sales resources, competition, reimbursement, and FirstGene. Finally, portfolio review became explicit.

Your challenge to the software explanation improved the analysis. Repetition by management is evidence that an explanation mattered to its public narrative. It is not an independent measurement of how much that factor contributed to the outcome.

The stronger finding was that the recovery thesis became less convincing while the opportunity cost of continuing to fund prenatal became more important. The sale could make sense even if FirstGene was scientifically sound and commercially promising.

The Myriad study makes that distinction explicit: 20261020 Myriad to Labcorp Prenatal.pdf

“The calls are just BS and hype”—a useful warning, but an inadequate method

Earnings calls are managed communications. Executives choose which metrics to emphasize, which comparisons to make, and how to describe setbacks. A favorable statement can be accurate while leaving the reader with an incomplete understanding.

That is precisely why reading a sequence can be productive.

Consider three hypothetical statements:

  • “Our gross margin improved.”
  • “Our restructuring is ahead of plan.”
  • “We expect growth to resume in the second half.”

The first may describe a measurable achievement. The second requires a definition of the plan and its baseline. The third is a forecast that can be checked later. Treating all three as either trustworthy information or empty promotion discards the distinctions that make analysis possible.

The most informative question is often: What does this favorable fact actually establish?

Higher gross margin does not establish adequate cash generation. Lower cash burn does not establish sufficient financing. A successful product launch does not establish physician adoption, reimbursement, or attractive returns. An improving subsidiary does not establish that retaining it is the parent’s best use of capital.

The three cases become interesting when we stop asking whether management was “positive” and examine the distance between its evidence and its conclusion.

Why four calls add more than four separate summaries

A sequence creates several tests that a single transcript cannot provide.

First, it creates a record of commitments. A forecast made in one quarter becomes a question for the next. Did the milestone occur? Was its deadline changed? Was the metric redefined? Did management explain the difference?

Second, it reveals how the explanation develops. A temporary disruption may become a customer-retention problem, then a commercial-execution problem, then a portfolio decision. That progression might reflect better understanding, changing conditions, selective presentation, or some combination. It deserves investigation without an automatic accusation of dishonesty.

Third, it makes persistent language informative. BioReference illustrates this particularly well. There need not be a dramatic rhetorical reversal. Repeatedly approaching the same objective without clearly reaching it can itself become the finding.

Fourth, it reveals which questions become harder to answer. Analyst Q&A is valuable when someone asks for a reconciliation: Why has recovery not occurred? How much financing is actually accessible? Does improved reported profit represent the continuing business? Analysts are not infallible, but their questions can expose the assumptions that prepared remarks leave implicit.

Fifth, it helps distinguish a business’s performance from its owner’s choices. The relevant unit of analysis can shift from a test, to a laboratory, to a corporate portfolio, to the claims of creditors and shareholders. Invitae makes the danger of collapsing those levels especially clear.

The deepest commonality: progress was not enough

Each company could point to improvements. Each still faced a different unresolved question:

  • BioReference: Would the retained operation generate durable earnings sufficient to justify continued ownership?
  • Invitae: Could the company finance the remaining journey to sustainability?
  • Myriad: Did prenatal offer a better use of incremental resources than the alternatives within the portfolio?

This suggests a useful discipline for any future four-call study: identify the constraint that matters most, then ask whether the reported progress actually relaxes it.

A company can spend considerable time discussing an improving metric that is relevant but insufficient. That need not be deception. Management may sincerely believe its achievements will eventually solve the larger problem. The analyst’s job is to examine the missing connection.

Labcorp gives the three cases a second analytical dimension

The buyer’s presence allows us to distinguish the value of operating assets from the success of the corporate structure that previously held them.

A laboratory can possess valuable assays, customer relationships, personnel, and data while struggling to generate satisfactory returns under a particular owner. A larger operator may anticipate using those assets differently or supporting them at lower incremental cost.

But the three outcomes should not be flattened into a single consolidation story. A negotiated divestiture and a bankruptcy sale occur under different constraints. The seller’s time, financing alternatives, and bargaining position matter. Purchase prices also cover different assets and liabilities.

Nor does Labcorp’s willingness to buy prove that its integration thesis will succeed. These cases document why ownership changed. A subsequent study would be needed to evaluate whether the new ownership delivered the expected economics.

The method needs safeguards against hindsight

The phrase “last four transcripts” is inherently retrospective. We selected these windows because we already knew something consequential happened afterward. That creates a temptation to make every earlier remark sound prophetic.

A fair study should ask two separate questions:

  1. What could a careful reader reasonably have concluded at that time?
  2. What does the later outcome help us understand about the earlier record?

The first supports contemporaneous judgment. The second supports historical explanation. They should not be presented as interchangeable.

Our three cases demonstrate explanatory usefulness; they do not establish predictive accuracy. To test prediction, we would also need companies with similar warnings or disappointing quarters that recovered, remained independent, or never sold. Otherwise, we cannot estimate false alarms.

Four calls are also a practical boundary, not a scientifically validated optimum. They provide repeated checkpoints, but acquisition history, financing terms, or reimbursement changes may require looking further back.

The strongest version is “four transcripts plus corroboration.” The calls organize the inquiry. Filings test liquidity and accounting claims. Transaction documents clarify what was sold. Product and payer evidence test commercial assumptions. Bankruptcy records can reveal constraints absent from earlier presentations.

That is also where AI is useful: aligning statements across quarters, finding changed forecasts, separating recurring from transaction-related figures, and organizing competing explanations. Its particular risk is producing an overly smooth story. The discipline is to preserve unresolved questions and label inference as inference.

The worthwhile lesson is that public corporate language can be analyzed without either believing it wholesale or dismissing it wholesale. These three studies found genuine progress, incomplete recoveries, shifting priorities, and materially different financial constraints. Reading the calls together made those distinctions visible—and made the eventual transactions more understandable without pretending they had been inevitable.

##

##

For Myriad you also hunted down an SEC document.

##

Yes—the October 20 Form 8-K and its attached asset purchase agreement, signed October 19. Those added information beyond the press release:

  • Myriad retains pre-closing accounts receivable, so selling the business does not eliminate its responsibility for collecting those balances.
  • The transaction includes employee offers, a patent license, and transition services.
  • The agreement specifies closing conditions, potential extensions, and a $10.5 million termination fee in certain regulatory circumstances. www.sec.gov

That improves our description of the method: the four transcripts provide the narrative spine; the SEC documents test and deepen the interpretation. The calls show how management explained the business over time. The agreement shows what the parties actually committed to transfer, retain, and undertake.

We also found the historical SEC acquisition disclosure that distinguished Counsyl’s $375 million announcement price from $405.9 million in subsequently reported consideration—another useful detail that a press-release-only review would miss. www.sec.gov

Sunday, October 18, 2026